SUPLASYN
Drug Identification Number (DIN)
00963631
Trade Name
SUPLASYN
Anatomical Therapeutic Chemical (ATC)
M09AX01
Drug Discontinued
Yes
Benefit Available
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Northwest Territories
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Benefit Category
Standard Benefit for Eligible Clients